Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | CA7 | P43166 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TACR1 | P25103 | 3/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29090089 | 1.00 | CA1 (0.49) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL4483094 | 0.89 | CA1 (0.53) | CA1CA2CA7CA9KMT2A | |
| Demannose SCHEMBL3007006 | 0.86 | TSHR (0.46) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL27957107 | 0.85 | CA1 (0.44) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL27957102 | 0.84 | CA1 (0.45) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL28201816 | 0.83 | CASR (0.45) | TACR1SLC1A1 | |
| SCHEMBL11684378 | 0.82 | LMNA (0.49) | KMT2ATSHR | |
| SCHEMBL11790408 | 0.82 | CA1 (0.46) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL1578761 | 0.81 | CA1 (0.45) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL5980669 | 0.81 | CA1 (0.45) | CA1CA2CA7CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2585087-A1 | A PREPARATION FOR BALANCING THE COMPOSITION OF THE ORAL MICROBIAL FLORA | Pärnänen, Pirjo (FI) | 2013-05-01 | — | — | EP | disclosed |
| WO-2011157898-A1 | A PREPARATION FOR BALANCING THE COMPOSITION OF THE ORAL MICROBIAL FLORA | PAERNAENEN PIRJO (FI) | 2011-12-22 | — | — | WO | disclosed |
| EP-0530850-B1 | Process for producing a modified oligosaccharide | WAKO PURE CHEM IND LTD (JP) | 1998-09-09 | — | — | EP | disclosed |
| US-5319078-A | α-amylase assay using modified oligosaccharide and process for producing said modified oligosaccharide | WAKO PURE CHEMICAL INDUSTRIES, INC. (JP) | 1994-06-07 | — | — | US | disclosed |
| EP-0252525-B1 | Alpha-amylase assay using modified oligosaccharide and process for producing said modified oligosaccharide | WAKO PURE CHEM IND LTD (JP) | 1993-11-10 | — | — | EP | disclosed |
| EP-0530850-A2 | Process for producing a modified oligosaccharide | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1993-03-10 | — | — | EP | disclosed |
| US-5192666-A | α-amylase assay using modified oligosaccharide and process for producing said modified oligosaccharide | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1993-03-09 | — | — | US | disclosed |
| US-4617269-A | WITH TRANSFERASE ENZYMES DERIVED FROM BACILLUS | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1986-10-14 | — | — | US | disclosed |